- MatsukiyoCocokara‘s FY operating income forecast is 77.50 billion yen, missing estimates of 82.57 billion yen.
- Net income is forecasted at 52.50 billion yen, which is lesser than the estimate of 55.38 billion yen.
- The forecasted net sales totals at around 1.05 trillion yen, which is lower than the estimate of 1.07 trillion yen.
- However, forecasted dividend at 42.00 yen is higher than the estimated 37.43 yen.
- First half forecast for net sales sits at 515.00 billion yen, net income at 26.00 billion yen and operating income at 38.00 billion yen.
- Fourth quarter results show an operating income of 16.96 billion yen, a year-on-year increase of 22%, though it fell short of estimated 17.35 billion yen.
- Net income during the fourth quarter was 10.05 billion yen, a 21% increase from last year, however less than the estimated 10.74 billion yen.
- Net sales in their fourth quarter amounted to 252.20 billion yen, which is a 6.4% increase from last year but slightly less than the estimate of 253.65 billion yen.
- The stock’s current status shows 9 buys, 5 holds, and 0 sells.
- All the comparisons to past results are from the company’s original disclosures.
A look at MatsukiyoCocokara Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts utilizing the Smartkarma Smart Scores have indicated a cautiously optimistic long-term outlook for MatsukiyoCocokara. With a solid score in resilience and value, the company appears well-positioned to weather uncertainties and provide stable returns for investors. However, lower scores in dividend and momentum suggest areas where improvement may be needed to attract dividend-focused investors and spur faster growth in the market.
MatsukiyoCocokara & Co., known for operating drug store chains retailing a range of products including medicines, cosmetics, and health foods, has diversified its business by also operating supermarkets and home centers. This diversification may contribute to its overall resilience, as indicated by its strong score in that category. Investors may find value in MatsukiyoCocokara‘s stable business model, despite the need for potential enhancements in dividend payouts and growth momentum.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
